Home > Income Statement > GLAND PHARMA

GLAND PHARMA
Revenue

    Back to Income Statement
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹5,617 Cr₹5,665 Cr₹3,625 Cr₹4,401 Cr₹3,463 Cr

What is the latest Revenue of GLAND PHARMA ?

The latest Revenue ratio of GLAND PHARMA is ₹5,617 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹5,617 Cr
Mar2025₹5,665 Cr
Mar2024₹3,625 Cr
Mar2023₹4,401 Cr
Mar2022₹3,463 Cr

How is Revenue of GLAND PHARMA Trending?

Years Revenue % Change
Mar2026 ₹5,617 Cr
-0.85
Mar2025 ₹5,665 Cr
56.29
Mar2024 ₹3,625 Cr
-17.64
Mar2023 ₹4,401 Cr
27.08
Mar2022 ₹3,463 Cr -

Compare Revenue of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹55,755.2 Cr 6.7% 9.2% 75.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹447,944.0 Cr -1.8% 7.6% 11.2% Stock Analytics
DIVIS LABORATORIES ₹294,962.0 Cr 3.7% 27.2% 71.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹178,391.0 Cr -2.3% 1.5% 23.6% Stock Analytics
DR REDDYS LABORATORIES ₹115,267.0 Cr 0.6% 13.4% 15.7% Stock Analytics
CIPLA ₹112,620.0 Cr -1.3% 6.1% -6.9% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

6.7%

9.2%

75.8%

SENSEX

0.7%

11.7%

-2%


You may also like the below Video Courses